Table VII.

Recommendations for determining lipid profile parameters as treatment targets in prevention of ischaemic heart disease

Recommendations	Class of recommendation	Level of evidence
LDL-C is recommended as the primary target of therapy	I	A
Total cholesterol determination should be considered where determination of other parameters is not available	IIa	A
Non-HDL-C determination should be considered as a secondary target of therapy, particularly in patients who have achieved target LDL-C levels	IIa I	B B
ApoB should be considered as a secondary target of therapy where its determination is possible	IIa	B
HDL-C is not recommended as a target of therapy	III	A